-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca: ZEGFROVY is now available in the US to treat previously treated patients with non-small cell lung cancer with EGFR exon 20 insertion mutations.

Zhitongcaijing·10/22/2026 12:17:26
Listen to the news
AstraZeneca: ZEGFROVY is now available in the US to treat previously treated patients with non-small cell lung cancer with EGFR exon 20 insertion mutations.